» Articles » PMID: 31896295

Attitudes Towards HPV Self-sampling Among Women in Chengdu, China: A Cross-sectional Survey

Overview
Journal J Med Screen
Specialty Public Health
Date 2020 Jan 4
PMID 31896295
Citations 6
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: Cervical cancer screening participation in China remains insufficient, possibly because of embarrassment or discomfort. We assessed knowledge of HPV and its link to cervical cancer, and whether HPV self-sampling might be an acceptable alternative to clinician-based screening, among Sichuan women.

Methods: A sample of healthy women undergoing routine physical examinations in 2017 at the West China Hospital, Sichuan University, completed a questionnaire.

Results: From 3000 questionnaires distributed, 1810 were completed and analyzed. Only 29.94% of respondents ( = 542) had heard of HPV, among whom 65.75% knew that it caused cervical cancer. Among the 766 (42.32%) who considered that HPV self-sampling for cervical cancer screening was an acceptable option, over 90% thought it would be convenient, private, not embarrassing, and not painful. However, 1044 women (57.68%) did not consider self-sampling acceptable, mainly because the result might not be accurate (85.63%), specimens may have gone bad (83.05%), and they may not perform the test correctly (79.98%). Respondents who believed HPV self-sampling was acceptable were more likely than other respondents to be young, and to have completed at least secondary education. Of the 1810 respondents, 1312 (72.49%) reported that they would be willing to be vaccinated against HPV.

Conclusion: Most women in Chengdu lack basic knowledge about HPV. Over 40% of women believed HPV self-sampling for cervical cancer screening was an acceptable option. To increase screening coverage, public health efforts to educate the public about HPV and HPV self-sampling for cervical cancer screening should be strengthened and expanded.

Citing Articles

Benefits and challenges of cervical cancer screening since the implementation of the 'two cancer' screening programme in China: findings from Shangyu, Zhejiang in 2019-23.

Wu Y, Luo J, Ye D, Gao S J Glob Health. 2025; 15:04064.

PMID: 40048317 PMC: 11884646. DOI: 10.7189/jogh.15.04064.


Human papillomavirus self-sampling versus provider-sampling in low- and middle-income countries: a scoping review of accuracy, acceptability, cost, uptake, and equity.

Otieno J, Were L, Nyanchoka M, Olwanda E, Mulaku M, Sem X Front Public Health. 2024; 12:1439164.

PMID: 39678248 PMC: 11638174. DOI: 10.3389/fpubh.2024.1439164.


HPV self-sampling for cervical cancer screening in China: A multi-center study.

Ji X, Hao M, Wang Y, Pan Z, Yang R, Wang X Heliyon. 2024; 10(21):e39544.

PMID: 39583834 PMC: 11582400. DOI: 10.1016/j.heliyon.2024.e39544.


Knowledge, attitudes, and practices of human papillomavirus and self-sampling among adult women: a cross-sectional study.

Shao J, Ke H, Jiang C, Sun H, Han H, Zhu J Front Public Health. 2024; 12:1377343.

PMID: 38894985 PMC: 11184059. DOI: 10.3389/fpubh.2024.1377343.


Prevalence of human papillomavirus genotypes and related cervical morphological results in southern Hunan Province of China, 2018-2020: Baseline measures at a tertiary institution prior to mass human papillomavirus vaccination.

Lan Z, Zhang J, Li H, He R, Zhao Q, Yang F Front Microbiol. 2023; 13:1094560.

PMID: 36687652 PMC: 9845708. DOI: 10.3389/fmicb.2022.1094560.